MOIRA QUINN: Open Payments
NPI 1407332216 · LEOMINSTER, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$426 in 28 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $14 · 2025 $426
Food & beverage: $426
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 15 | $145 |
| ABBVIE INC. | 6 | $128 |
| Janssen Biotech, Inc. | 3 | $76 |
| Amgen Inc. | 1 | $28 |
| Incyte Corporation | 1 | $26 |
| Novartis Pharmaceuticals Corporation | 1 | $17 |
| Organon LLC | 1 | $6 |
Products named: Zoryve, SKYRIZI, TREMFYA, RINVOQ, OTEZLA, OPZELURA, COSENTYX.
Industry payments across MA — which companies pay providers there.
